that, in turn, will increase the sensitivity of whole body scan for residual or recurrent thyroid cancer. Two doses of 0.9 mg rhTSH, 24 hours apart, are optimal to achieve peak TSH concentrations of 60 -240 IU/mL 24 h after the second dose, and to maintain a 25-30 IU/mL therapeutic concentration on the day of 131 I administration (4, 5 ) . The increased TSH concentration was due in our patient to 2 injections of rhTSH on the days prior to the laboratory testing. Although the measured TSH concentration (22.5 IU/mL) was slightly lower than desired, whole body radioiodine scan was performed, and it did not disclose signs of recurrence. 
